Kenneth L. Davis, MD, President and CEO of Mount Sinai, in Forbes: The Hunt For A Zika Vaccine
Recent advances in the hunt for a Zika vaccine bring a glimmer of hope in the battle against a disease threatening to spread across the globe, but also recognition of just how difficult it is to defeat this malignant virus. Read the article
A New Vision of Mount Sinai Downtown
Sweeping change in the practice of health care is leading to a transformation in the Mount Sinai Health System’s downtown footprint. A planned investment of more than $500 million will create the new “Mount Sinai Downtown,” an expanded and unified network of...
Kenneth L. Davis, MD, President and CEO of Mount Sinai, in Forbes: Price Gougers Like Valeant Pharmaceuticals Must Be Tamed
It’s time to unleash the power of free-market economics to resolve a continuing outrage in the generic drug industry. Price gouging by rogue financial operators posing as pharma companies, most notably Valeant Pharmaceuticals and Turing Pharmaceuticals AG, has been...